Myomo, Inc. (MYO) insider buying and SEC filings
Myomo, Inc. · CIK 1369290
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- MYOMO INC
Insider activity in the last 12 months
Bought
$434K
Insiders who bought
3
Sold (not marked 10b5-1)
$259K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 11, 2026 | Sale Amended filing | Harry Kovelman (Chief Medical Officer) sold 15,844 shares at $1.27 ($20K). Holdings down 15% to 89,889 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Sep 14. | SEC filing Filed Oct 15, 2026, 4:28 PM ET |
| Sep 2, 2026 | Sale | Milton Mayo Morris (Director) sold 15,000 shares at $1.41 ($21K). Holdings down 7% to 208,391 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 4, 2026 |
| Aug 20, 2026 | Sale Amended filing | Harry Kovelman (Chief Medical Officer) sold 17,500 shares at about $1.73 ($30K). Holdings down 14% to 105,733 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Aug 21. | SEC filing Filed Aug 24, 2026 |
| Jun 5, 2026 | Open-market purchase | Thomas F. Kirk (Director) bought 40,002 shares at about $1.27 ($51K) in an open-market purchase. Holdings up 6% to 693,865 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| May 14, 2025–May 14, 2026 | Sale Amended filing | Micah Mitchell (Chief Commercial Officer) sold 180,462 shares between May 14, 2025 and May 14 at about $0.8600 ($155K). Holdings down 62% to 109,478 shares. Not marked as a 10b5-1 plan trade. This amends a filing from May 15. | SEC filing Filed Jun 8, 2026 |
| May 28, 2026 | Open-market purchase | Thomas F. Kirk (Director) bought 25,000 shares at $0.9900 ($25K) in an open-market purchase. Holdings up 4% to 653,863 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 1, 2026 |
| May 27–28, 2026 | Sale | Harry Kovelman (Chief Medical Officer) sold 32,000 shares between May 27 and May 28 at about $1.01 ($32K). Holdings down 23% to 108,618 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 28, 2026 |
| May 15–18, 2026 | Open-market purchase | Thomas F. Kirk (Director) bought 75,006 shares between May 15 and May 18 at about $0.9100 ($68K) in an open-market purchase. Holdings up 14% to 628,863 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| May 14–15, 2026 | Purchase (code P) | Joseph M. Manko Jr. (Director) bought 201,197 shares indirectly (by entity) between May 14 and May 15 at about $0.8645 ($174K), reported as a purchase (code P). Holdings by entity up 10% to 2,309,775 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| Mar 16, 2026 | Open-market purchase | Heather C Getz (Director) bought 20,000 shares at $0.7000 ($14K) in an open-market purchase. Holdings up 18% to 131,754 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 17, 2026 |
| Mar 13, 2026 | Open-market purchase | Thomas F. Kirk (Director) bought 72,000 shares at about $0.7100 ($51K) in an open-market purchase. Holdings up 15% to 553,857 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 12, 2026 | Open-market purchase | Heather C Getz (Director) bought 70,000 shares at about $0.7300 ($51K) in an open-market purchase. Holdings up 168% to 111,754 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 12, 2026 |
| Nov 20–21, 2025 | Open-market purchase | Thomas F. Kirk (Director) bought 7,437 shares between Nov 20, 2025 and Nov 21, 2025 at $0.7200 ($5K) in an open-market purchase. Holdings up 2% to 481,857 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 18–19, 2025 | Open-market purchase | Thomas Aloysius Crowley Jr. (Director) bought 4,385 shares directly and indirectly (by family member) between Nov 18, 2025 and Nov 19, 2025 at about $0.7335 ($3K) in an open-market purchase. Direct holdings up 6% to 75,748 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 21, 2025 |
29 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$318K in purchases since May 15, 2026 · Purchases traded May 15, 2026 to Jun 5, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Joseph M. Manko Jr. (Director) | $174K | May 15, 2026 | SEC filing |
| Thomas F. Kirk (Director) | $68K | May 18, 2026 | SEC filing |
| Thomas F. Kirk (Director) | $25K | May 28, 2026 | SEC filing |
| Thomas F. Kirk (Director) | $51K | Jun 5, 2026 | SEC filing |
2 insiders bought in 30 days
$116K in purchases since Mar 12, 2026 · Purchases traded Mar 12, 2026 to Mar 16, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Heather C Getz (Director) | $51K | Mar 12, 2026 | SEC filing |
| Thomas F. Kirk (Director) | $51K | Mar 13, 2026 | SEC filing |
| Heather C Getz (Director) | $14K | Mar 16, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MYO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.